Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden ; volume:6 ; number:1 ; day:9 ; month:5 ; year:2018 ; pages:1-12 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (9.5.2018), 1-12, 12.2018

Creator: Morrison, Carl

Contributor: Pabla, Sarabjot
Conroy, Jeffrey M.
Nesline, Mary K.
Glenn, Sean T.
Dressman, Devin
Papanicolau-Sengos, Antonios
Burgher, Blake
Andreas, Jonathan
Giamo, Vincent
Qin, Moachun
Wang, Yirong
Lenzo, Felicia L.
Omilian, Angela
Bshara, Wiam
Zibelman, Matthew
Ghatalia, Pooja
Dragnev, Konstantin
Shirai, Keisuke
Madden, Katherine G.
Tafe, Laura J.
Shah, Neel
Kasuganti, Deepa
de la Cruz-Merino, Luis
Araujo, Isabel
Saenger, Yvonne
Bogardus, Margaret
Villalona-Calero, Miguel
Diaz, Zuanel
Day, Roger
Eisenberg, Marcia
Anderson, Steven M.
Puzanov, Igor
Galluzzi, Lorenzo
Gardner, Mark
Ernstoff, Marc S.
SpringerLink (Online service)

DOI: 10.1186/s40425-018-0344-8

URN: urn:nbn:de:101:1-2018072917040983738546

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Morrison, Carl
Pabla, Sarabjot
Conroy, Jeffrey M.
Nesline, Mary K.
Glenn, Sean T.
Dressman, Devin
Papanicolau-Sengos, Antonios
Burgher, Blake
Andreas, Jonathan
Giamo, Vincent
Qin, Moachun
Wang, Yirong
Lenzo, Felicia L.
Omilian, Angela
Bshara, Wiam
Zibelman, Matthew
Ghatalia, Pooja
Dragnev, Konstantin
Shirai, Keisuke
Madden, Katherine G.
Tafe, Laura J.
Shah, Neel
Kasuganti, Deepa
de la Cruz-Merino, Luis
Araujo, Isabel
Saenger, Yvonne
Bogardus, Margaret
Villalona-Calero, Miguel
Diaz, Zuanel
Day, Roger
Eisenberg, Marcia
Anderson, Steven M.
Puzanov, Igor
Galluzzi, Lorenzo
Gardner, Mark
Ernstoff, Marc S.
SpringerLink (Online service)

Other Objects (12)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Related objects

Reset password